Avancerad sökning
Visar resultat 21 - 25 av 85 avhandlingar som matchar ovanstående sökkriterier.
21. Drug resistance in acute myeloid leukemia : pharmacokinetic and in vitro studies
Sammanfattning : Chemotherapy has improved clinical outcome in adult acute myeloid leukemia (AML) but still the majority of the patients die of their disease. One important explanation is transport mediated drug resistance resulting in refractory or relapsing disease. P-glycoprotein (Pgp) is located in the membrane and can extrude cytostatic drugs. LÄS MER
22. Pharmacogenetic studies in childhood acute lymphoblastic leukaemia with primary focus on methotrexate
Sammanfattning : Childhood acute lymphoblastic leukaemia is the most common type of cancer in children. Improvement in treatment has increased survival to approximately 85 per cent. LÄS MER
23. Toxicity of metal containing micro- and nanoparticles : studies from an inhalation perspective
Sammanfattning : Particles in urban environments have for a long time been associated with different health problems and diseases, such as worsening of asthma and chronic obstructive pulmonary disease as well as cancer and cardiovascular diseases. In addition, metal containing particles present in occupational settings and industries, particularly particles produced during welding, have been linked to several adverse health effects. LÄS MER
24. Acute myeloid leukemia : apoptotic signalling and gene expression associated with treatment response
Sammanfattning : Acute myeloid leukemia (AML) is a severe, life threatening malignancy characterized by a clonal expansion of immature myeloid cells in the bone marrow, resulting in severe infections and bleedings. High dose chemotherapy is able to normalize the blood and bone marrow morphology (complete remission, CR) in a majority of treated patients, but recurrent disease, typically occurs within 1-2 years. LÄS MER
25. Inhibition of acute allogaft rejection - experimental transplant studies with biological and chemical immunosuppressants
Sammanfattning : In clinical transplantation immunosuppressive agents are used in combination with the objective to achieve additive effects and less toxicity. A large number of novel drugs are candidates for clinical introduction at this time and experiments in animal models have an important role to play. LÄS MER